Science
Mechanism of Action
Acetyl Hexapeptide-22, also identified as Acetyl Hexapeptide-8 or Argireline, functions by mimicking the N-terminus of SNAP-25, a protein essential for neurotransmitter release. It competitively inhibits the SNAP-25 component of the SNARE complex, which is critical for the docking and fusion of acetylcholine-releasing vesicles. By destabilizing this complex, it prevents acetylcholine release, thereby reducing muscle contractions and, consequently, minimizing the formation of expression lines and wrinkles. This mechanism positions it as a 'botox-like' peptide for topical application.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Significant improvements in wrinkle depth and number after four weeks.
- 02 Decreased wrinkle depth by 17% around the eyes.
- 03 Decreased wrinkle depth by 16.26%.
- 04 Increased skin moisturization and significantly decreased both the depth and width of wrinkles.
- 05 Inhibited muscle contractions by 26% in an in vitro study.
- 06 Daily topical application was found to be safe and promising for prolonging the action of injectable botulinum neurotoxin therapy.
Transparency
Dusting Analysis
The Expert Panel for Cosmetic Ingredient Safety (CIR) deemed Acetyl Hexapeptide-8 (a synonym for Acetyl Hexapeptide-22) safe up to 0.005%, citing insufficient data for higher concentrations. However, clinical studies demonstrating anti-wrinkle efficacy utilize significantly higher concentrations, ranging from 0.05% to 10%. This considerable disparity between the CIR-recommended safety limit and effective concentrations suggests that products formulated for clinical benefits may exceed established safety guidelines, or conversely, products adhering to safety limits may not deliver desired efficacy.
The Formula
Formulation
Stability
Acetyl Hexapeptide-22 (Acetyl Hexapeptide-8) exhibits limited cutaneous absorption due to its hydrophilic nature and relatively large molecular size (889 Da). Formulation strategies, such as oil-in-water (O/W) and water-in-oil-in-water (W/O/W) emulsions, are explored to enhance its delivery. While the optimal pH for stability is between 4.0 and 7.0, permeability through the skin has been shown to be significantly higher in acidic environments (e.g., pH 2.7) compared to alkaline conditions (pH 7.4).
Safety
Safety Profile
The Expert Panel for Cosmetic Ingredient Safety (CIR) concluded that Acetyl Hexapeptide-8 Amide (synonymous with Acetyl Hexapeptide-8) is safe for cosmetic use at concentrations up to 0.005%. Data were found insufficient to evaluate safety at higher concentrations. The FDA does not categorize 'cosmeceuticals,' regulating products as either cosmetics or drugs. No specific SCCS status is available in the provided data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Acetyl Hexapeptide-22 offers a scientifically validated 'botox-like' mechanism for wrinkle reduction, its practical application is challenged by a significant discrepancy between the CIR-recommended safe concentration (0.005%) and the much higher concentrations (0.05%-10%) proven effective in clinical studies.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources